Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | THRB | P10828 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 3/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| N,N-Dimethylethanaminium SCHEMBL23833781 | 0.81 | ALDH1A1 (0.37) | ALDH1A1THRBTSHR | |
| N,N-Dimethylethanaminium SCHEMBL8023992 | 0.76 | THRB (0.47) | ALDH1A1THRBTSHR | |
| N,N-Dimethylethanaminium SCHEMBL7866527 | 0.76 | THRB (0.47) | ALDH1A1THRBTSHR | |
| N,N-Dimethylethanaminium SCHEMBL8023985 | 0.76 | THRB (0.47) | ALDH1A1THRBTSHR | |
| SCHEMBL2867756 | 0.75 | ALDH1A1 (0.41) | ALDH1A1THRBTSHR | |
| N,N-Dimethylethanaminium SCHEMBL4258895 | 0.75 | THRB (0.42) | ALDH1A1THRBTSHR | |
| SCHEMBL1255334 | 0.73 | ALDH1A1 (0.39) | ALDH1A1THRBTSHR | |
| SCHEMBL29167456 | 0.73 | ALDH1A1 (0.39) | ALDH1A1THRBTSHR | |
| SCHEMBL29167479 | 0.73 | ALDH1A1 (0.39) | ALDH1A1THRBTSHR | |
| SCHEMBL1255357 | 0.73 | ALDH1A1 (0.39) | ALDH1A1THRBTSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12553188-B2 | GPAM compositions and methods | KEMIRA OYJ (FI) | 2026-02-17 | — | — | US | disclosed |
| US-20230135892-A1 | GPAM COMPOSITIONS AND METHODS | KEMIRA OYJ (FI) | 2023-05-04 | — | — | US | disclosed |
| EP-4093820-A1 | GPAM COMPOSITIONS AND METHODS | Kemira Oyj (FI) | 2022-11-30 | — | — | EP | disclosed |
| WO-2021188701-A1 | GPAM COMPOSITIONS AND METHODS | KEMIRA OYJ (FI) | 2021-09-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12553188-B2 | GPAM compositions and methods | PGM2, SLC6A9, GNMT | ALDH1A1 3411/4885THRB 4162/4885TSHR 4437/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.